In Focus

South Korea stays attractive to pharma sector despite drug approval lag

High spending and an innovative R&D environment are expected to ensure attractiveness.
3 days ago

South Korea stays attractive to pharma sector despite drug approval lag

High spending and an innovative R&D environment are expected to ensure attractiveness.
3 days ago

Eye specialist works to overcome resistance to AI Myopia screening

Some parents are wary of AI's ability to provide a holistic assessment compared to physicians. 
4 days ago

New pastures to reward healthcare investors in APAC: report

Some private equity investors have been diversifying to Southeast Asia, India, and Japan.

Foreign players to play key role in China's cardiovascular disease approach

The country is heavily reliant on foreign players in CVD management.

Economic growth, political stability boost Cambodia’s pharma market

The sector’s 2023 growth is expected to come from a low base effect from 2022.

Neurology diagnostics solutions to boost Japan's medical devices industry

Certain novel solutions could support the nuclear imaging equipment market in Japan.

India eyes database on drug formulations in the country

This will help address issues on the quality of drugs in the market, Fitch Solutions said.

Chinese drugmakers pushed towards drugs for new COVID-19 variants

Some 19 COVID-19 drugs are in various phases of clinical development in the country.

South Korean hospitals in need of AI transformation to improve diagnostics

The diagnostic imaging market is seen to grow at 5% between 2023 and 2030.

Singapore's shift to preventive care to address healthcare costs: report

The country plans to roll out a healthcare platform to make healthcare accessible.

Ageing population to boost ASEAN medical diagnostics market

The market is expected to grow at a CAGR of 12.6% over the medium term.

South Korea’s next generation sequencing set to take off: report

There has been a growing interest towards researching cancer screening in the country.

China’s pivot to domestic medical devices market could discourage MNCs: report

Some local ministries banned public institutions from procuring imported medical equipment.

More awareness needed over stroke's disease burden in India: report

Only one in five is aware of the risk factors of stroke in the country.

Opportunities for drugmakers in Cambodia limited despite rising diseases

Low government funding has affected the quality of healthcare in public hospitals.

Australia's incentives for domestic manufacturing to create opportunities

The country's science agency opened a new national lab in Melbourne.

Japan’s over-the-counter drugs sector in the doldrums

An elevated demand for prescription drugs has held back demand for OTC drugs.